1. Home
  2. SABR vs EMBC Comparison

SABR vs EMBC Comparison

Compare SABR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabre Corporation

SABR

Sabre Corporation

HOLD

Current Price

$1.50

Market Cap

580.9M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.03

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABR
EMBC
Founded
2006
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.9M
521.7M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
SABR
EMBC
Price
$1.50
$9.03
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$2.50
$18.50
AVG Volume (30 Days)
13.4M
748.8K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
6.75%
EPS Growth
283.56
20.90
EPS
1.34
0.74
Revenue
$3,866,956,000.00
N/A
Revenue This Year
$7.40
$1.17
Revenue Next Year
$3.26
N/A
P/E Ratio
$0.98
$12.04
Revenue Growth
7.46
N/A
52 Week Low
$0.81
$8.72
52 Week High
$3.51
$15.55

Technical Indicators

Market Signals
Indicator
SABR
EMBC
Relative Strength Index (RSI) 52.88 39.08
Support Level $1.49 N/A
Resistance Level $1.70 $10.88
Average True Range (ATR) 0.17 0.34
MACD -0.03 0.03
Stochastic Oscillator 29.29 27.23

Price Performance

Historical Comparison
SABR
EMBC

About SABR Sabre Corporation

Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: